Cardiovascular complications of chemotherapy: A synopsis

It is important to identify chemotherapy-related cardiotoxicity as it may impact on the overall survival of cancer patients. The various forms of cardiotoxicity encountered during and after chemotherapy for cancer, include impaired left ventricular function leading to cardiomyopathy (CMO), myocardia...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Len Steingo
Formato:	article
Lenguaje:	EN
Publicado:	South African Heart Association 2017
Materias:	chemotherapy cardiomyopathy myocardial ischaemia Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/0e869fe40d094656bc4768d41b83dfe7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0e869fe40d094656bc4768d41b83dfe7
record_format	dspace
spelling	oai:doaj.org-article:0e869fe40d094656bc4768d41b83dfe72021-11-29T13:16:17ZCardiovascular complications of chemotherapy: A synopsis10.24170/9-4-18311996-67412071-4602https://doaj.org/article/0e869fe40d094656bc4768d41b83dfe72017-04-01T00:00:00Zhttps://www.journals.ac.za/index.php/SAHJ/article/view/1831https://doaj.org/toc/1996-6741https://doaj.org/toc/2071-4602It is important to identify chemotherapy-related cardiotoxicity as it may impact on the overall survival of cancer patients. The various forms of cardiotoxicity encountered during and after chemotherapy for cancer, include impaired left ventricular function leading to cardiomyopathy (CMO), myocardial ischaemia, hypertension (HTN), thromboembolic states, bradycardia and prolongation of the QT interval predisposing to ventricular arrhythmias. The relationships between specific chemotherapeutic agents and the occurrence of these complications are discussed, highlighting the need for close collaboration between oncologists and cardiologists.Len SteingoSouth African Heart Associationarticlechemotherapycardiomyopathymyocardial ischaemiaDiseases of the circulatory (Cardiovascular) systemRC666-701ENSA Heart Journal, Vol 9, Iss 4, Pp 274-279 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	chemotherapy cardiomyopathy myocardial ischaemia Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	chemotherapy cardiomyopathy myocardial ischaemia Diseases of the circulatory (Cardiovascular) system RC666-701 Len Steingo Cardiovascular complications of chemotherapy: A synopsis
description	It is important to identify chemotherapy-related cardiotoxicity as it may impact on the overall survival of cancer patients. The various forms of cardiotoxicity encountered during and after chemotherapy for cancer, include impaired left ventricular function leading to cardiomyopathy (CMO), myocardial ischaemia, hypertension (HTN), thromboembolic states, bradycardia and prolongation of the QT interval predisposing to ventricular arrhythmias. The relationships between specific chemotherapeutic agents and the occurrence of these complications are discussed, highlighting the need for close collaboration between oncologists and cardiologists.
format	article
author	Len Steingo
author_facet	Len Steingo
author_sort	Len Steingo
title	Cardiovascular complications of chemotherapy: A synopsis
title_short	Cardiovascular complications of chemotherapy: A synopsis
title_full	Cardiovascular complications of chemotherapy: A synopsis
title_fullStr	Cardiovascular complications of chemotherapy: A synopsis
title_full_unstemmed	Cardiovascular complications of chemotherapy: A synopsis
title_sort	cardiovascular complications of chemotherapy: a synopsis
publisher	South African Heart Association
publishDate	2017
url	https://doaj.org/article/0e869fe40d094656bc4768d41b83dfe7
work_keys_str_mv	AT lensteingo cardiovascularcomplicationsofchemotherapyasynopsis
_version_	1718407327525109760

Cardiovascular complications of chemotherapy: A synopsis

Ejemplares similares